Intrathecal Hydromorphone for Intractable Nonmalignant Pain: A Retrospective Study
نویسندگان
چکیده
منابع مشابه
Long-term use of intrathecal droperidol as an excellent antiemetic in nonmalignant pain--a retrospective study.
UNLABELLED Over the past five years our pain practice encountered eight patients (5 female, 3 male) with chronic non-malignant pain syndromes, in whom any meaningful pain reduction via opioid analgesics (either by oral or systemic and/or intraspinal route) had resulted in profound nausea and/or vomiting despite generous use of available and/or affordable anti-emetics. After obtaining proper con...
متن کاملIntrathecal hydromorphone for postoperative analgesia after cesarean delivery: a retrospective study.
Despite compelling evidence for the safety and efficacy of intrathecal hydromorphone, the use of this opioid intrathecally for the pain management of patients undergoing cesarean delivery has not been widely accepted. The purpose of this retrospective study was to compare the reported efficacy and safety of pain management in women who received intrathecal hydromorphone (100 microg) vs in women...
متن کاملIntrathecal opioids for chronic nonmalignant pain: a case study and the search for balance.
Report of the NIH Task Force on Research Standards for Chronic Low Back Pain Richard A. Deyo, MD, MPH, Samuel F. Dworkin, DDS, PhD, Dagmar Amtmann, PhD, Gunnar Andersson, MD, PhD, David Borenstein, MD, Eugene Carragee, MD, John Carrino, MD, MPH, Roger Chou, MD, Karon Cook, PhD, Anthony DeLitto, PT, PhD, Christine Goertz, DC, PhD, Partap Khalsa, DC, PhD, John Loeser, MD, Sean Mackey, MD, PhD, Ja...
متن کاملUse of intrathecal bupivacaine in refractory chronic nonmalignant pain.
OBJECTIVE To demonstrate the efficacy and safety of the addition of bupivacaine in restoring pain control and improving quality of life and activity level in patients with chronic nonmalignant pain refractory to intrathecal opioids. DESIGN Retrospective study. SETTING Outpatient clinics. PATIENTS Seventeen patients with inadequate pain relief while receiving intrathecal opioids alone. Int...
متن کاملOnce-daily OROS® hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study
BACKGROUND The use of opioid analgesics for patients with chronic nonmalignant pain is becoming more widely accepted, and long-acting formulations are an important treatment option. AIM To assess conversion to extended-release OROS hydromorphone from previous stable opioid agonist therapy in patients with chronic nonmalignant pain of moderate-to-severe intensity. METHODS In this open-label ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pain Medicine
سال: 2006
ISSN: 1526-2375,1526-4637
DOI: 10.1111/j.1526-4637.2006.00083.x